Industry Braces For More Price Cuts As Turkey Eyes Prevention To Tame Soaring Costs
This article was originally published in PharmAsia News
Executive Summary
Turkey paid TL3.5 billion ($1.8 billion) in 2012 on drugs and treatments for cancer patients, a 25% increase over two years that has caused budget pressure and added to shortages of critical oncology medicines, prompting an industry insider to speculate the government will seek more price cuts to contain costs.